Business Services Industry

Stock in drug maker IVAX plummets 23 percent in generics price war.

Knight Ridder/Tribune Business News, November, 2004

By John Dorschner, The Miami Herald Knight Ridder/Tribune Business News

Nov. 2--Miami drug maker IVAX reported Monday that third-quarter net income more than doubled over the same period last year, but the stock plummeted 23 percent because of price wars in the generic drug market.

"Cheaper generics create cheaper generic stocks," said Andrew Forman, an analyst with Advest.

The firm reported revenue of $439.1 million for the quarter, up 22 percent from the same period in 2003. Net income was $44.4 million -- more than double the $21.6 million for the third quarter last year.

But analysts had been expecting more. "They came in below expectations," said Herman Saftlas, an analyst with Standard & Poor's, which downgraded IVAX...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here